In this study we investigate the impact of diagnostic delays on breast cancer mortality, caused by public health measures introduced as a response to the COVID-19 pandemic. We establish a Markov model based on available data and medical literature for women aged 65–89 years. We quantify age-specific, short-term excess deaths, for a period up to 5 years, along with years of life expectancy lost and change in cancer mortality by cancer stage, based on an assumption relating to declines in breast cancer diagnosis amid the pandemic. Our analysis suggests a 5–8% increase in BC deaths of women, with no BC, across different ages.
|Publication status||Published - 16 Feb 2023|
|Event||2023 Living to 100 Research Symposium - Asia - Hong Kong, Hong Kong|
Duration: 16 Feb 2023 → 16 Feb 2023
|Conference||2023 Living to 100 Research Symposium - Asia|
|Period||16/02/23 → 16/02/23|